Evotec SE (EVO) Cash from Investing Activities (2021 - 2026)

Evotec SE's (EVO) quarterly Cash from Investing Activities came in at -$14557.1 in Q1 2026, up 35.95% year-on-year from -$10707.6 in Q1 2025, and down 100.01% quarter-over-quarter from $199.8 million in Q4 2025.

Evotec SE (EVO) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Evotec SE has disclosed Cash from Investing Activities across 6 years of filings, most recently posting -$14557.1 for Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at -$14557.1, up 35.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $199.8 million (up 362.62% YoY), and the FY2025 annual result was $199.7 million, up 362.57% from the prior year.
  • Cash from Investing Activities came in at -$14557.1 for Q1 2026 at Evotec SE, down from $199.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $199.8 million in Q4 2025 to a low of -$420.7 million in Q4 2022.
  • The 5-year median for Cash from Investing Activities is -$28464.8 (2024), against an average of -$18.3 million.
  • Across the five-year window, Cash from Investing Activities slumped 191439.37% in 2022 and surged 362.98% in 2025, its largest moves.
  • Evotec SE's Cash from Investing Activities stood at -$420.7 million in 2022, then surged by 96.6% to -$14.3 million in 2023, then plunged by 430.62% to -$76.0 million in 2024, then soared by 362.98% to $199.8 million in 2025, then plunged by 100.01% to -$14557.1 in 2026.
  • The last three Cash from Investing Activities figures came in at -$14557.1 (Q1 2026), $199.8 million (Q4 2025), and -$8465.1 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 Evotec SE 570.60 Mn 570.08 Mn - -14,557.05

Historic Data

Download Data
DateValue
Mar 31, 2026 -14,557.05
Mar 31, 2026 -14,557.05
Dec 31, 2025 199.80 Mn
Dec 31, 2025 199.80 Mn
Sep 30, 2025 -8,465.13
Sep 30, 2025 -8,465.13
Jun 30, 2025 -24,838.59
Jun 30, 2025 -24,838.59
Mar 31, 2025 -22,728.07
Mar 31, 2025 -22,728.07
Dec 31, 2024 -75.98 Mn
Dec 31, 2024 -75.98 Mn
Sep 30, 2024 -28,464.75
Sep 30, 2024 -28,464.75
Jun 30, 2024 -33,687.20
Jun 30, 2024 -33,687.20
Mar 31, 2024 -33,576.18
Mar 31, 2024 -33,576.18
Dec 31, 2023 -14.32 Mn
Dec 31, 2023 -14.32 Mn